Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL651086 | 0.93 | C5AR1 (0.52) | C5AR1SMN1; SMN2PPARGPPARATDP1 | |
| SCHEMBL5073974 | 0.91 | C5AR1 (0.55) | C5AR1SMN1; SMN2MAPTPPARGPPARA | |
| SCHEMBL5136237 | 0.91 | C5AR1 (0.55) | C5AR1SMN1; SMN2MAPTPPARGPPARA | |
| SCHEMBL5134857 | 0.91 | C5AR1 (0.60) | C5AR1SMN1; SMN2PPARGPPARATDP1 | |
| SCHEMBL647999 | 0.91 | C5AR1 (0.62) | C5AR1SMN1; SMN2MAPTPPARGPPARA | |
| SCHEMBL4764164 | 0.90 | C5AR1 (0.54) | C5AR1SMN1; SMN2MAPTPPARGPPARA | |
| SCHEMBL5136163 | 0.89 | C5AR1 (0.55) | C5AR1SMN1; SMN2PPARGPPARATDP1 | |
| SCHEMBL5136174 | 0.89 | C5AR1 (0.58) | C5AR1SMN1; SMN2PPARGPPARATDP1 | |
| SCHEMBL5073883 | 0.89 | C5AR1 (0.58) | C5AR1SMN1; SMN2MAPTPPARGPPARA | |
| SCHEMBL4765625 | 0.88 | C5AR1 (0.57) | C5AR1SMN1; SMN2PPARGPPARATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |